Already a member? Login to access this report free.
Report Highlights
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Report Includes
- 53 data tables and 29 additional tables
- An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment’s future commercial potential
- Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
- Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
- A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA’s contribution to COVID-19 diagnostic testing
- A review of patents and new developments in PCR POC technologies
- Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN
Report Scope
This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.
The market is divided into segments and by application/industry:
By Product type:
- POC PCR analyzers.
- Consumables.
By analyte:
- POC PCR analyzers.
- Single analyte.
- Multi-analyte.
- Consumables.
- Single analyte.
- Multi-analyte.
By Application:
- Infectious diseases.
- Sexually transmitted diseases (STIs).
- Other diseases.
Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.
Report Synopsis
| Report Metrics | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||
| Forecast period considered | 2024-2029 | ||||||||
| Base year market size | $1.6 Billion | ||||||||
| Market size forecast | $2.1 Billion | ||||||||
| Growth rate | CAGR of 5.9% from 2024 to 2029 | ||||||||
| Units considered | $ Millions | ||||||||
| Segments covered | By Product Type, Analyte, Application and Region | ||||||||
| Regions covered | North America, Europe, Asia-Pacific, Latin America, and Rest of the World (RoW) | ||||||||
| Countries covered | The U.S., Canada, Mexico, Brazil, Argentina, Chile, Germany, U.K., France, Italy, Spain, Japan, China, India, Middle East and Africa | ||||||||
| Key Market Drivers |
|
||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Related Reports
2024 Diagnostics Research Review
The Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Polymerase Chain Reaction (PCR) Technologies and Global Markets
The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.
Digital Polymerase Chain Reaction (dPCR) Technology: Global Markets
The global market for digital polymerase chain reaction (dPCR) technology is expected to grow from $752.1 million in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023-2028.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics should grow from nearly $3.3 billion in 2020 to $5.0 billion by 2025, at a compound annual growth rate (CAGR) of 9.1% during the period of 2020-2025.
Report Includes
- 18 data tables and 23 additional tables
- A comprehensive overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with future commercial potential for each key market segment
- Analyses of the global market trends, with data from 2019 and 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Estimation of the actual market size and revenue forecasts for the global PCR for POC diagnostics market and potential end-users for types of kits and equipment
- Identification of the emerging market opportunities and future market potential of the PCR for POC diagnostics industry, technology trends and issues, market determinants, and regulatory frameworks pertaining to PCR technology
- Competitive landscape specific to COVID-19 impact analysis, with emphasis on FDA’s contribution to COVID-19 diagnostic testing and key developments within the segment
- Patent review and new developments in POC PCR technologies, by companies or research institutes
- Discussion of the vendor landscape and detailed profiles of major vendors in the global PCR for POC diagnostics market. Major players include Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid, Roche Diagnostics and Qiagen N.V.
Report Highlights
The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.
Report Includes
- An overview of the global market for polymerase chain reaction (PCR) in point-of-care (POC) diagnostics
- Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Detailed analysis of point-of-care molecular diagnostics, technological trends, and governmental regulatory policies
- Examination of various segments of the POC-PCR market, including cyclers, systems, applications, and cartridges
- Patent analyses
- Company profiles of major players in the market, including Abbott Laboratories, Atlas Genetics, Cepheid Inc., Fluxergy and Roche Diagnostics
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More